The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Anja Meissner

WCMM Fellow | Vascular Biology

Our research

Cardiovascular disease, such as heart attack, stroke, and peripheral vascular disease, is the number-one health problem in the world. Despite remarkable progress in diagnosis and prevention, cardiovascular diseases cause disability and death at an astounding rate. The best opportunities to develop and implement new strategies for preventing and treating cardiovascular disease lie in the understanding of its underlying mechanisms.

Anja Meissner’s research focuses on repair and regeneration of the cardiovascular system and specifically, in understanding sphingosine-1-phosphate signaling and its role in the regulation of the vascular and the immune system during cardiovascular disease and associated target organ inflammation.

Aims

  • To identify molecular mechanisms underlying cardiovascular disease and associated target organ involvement.

Impact

| Research Output

Strengths of the group

  • Murine models of cardiovascular disease
  • Sphingosine-1-phosphate signaling

Affiliations

  • Wallenberg Center for Molecular Medicine
  • Dept of Experimental Medical Science
  • Institute for Theoretical Medicine, University of Augsburg, Germany
  • German Center for Neurodegenerative Diseases, Bonn, Germany

Social media

 

Anja Meissner. Portrait

Anja Meissner

Principal Investigator

Phone: +46 46 222 06 41

Email: anja [dot] meissner [at] med [dot] lu [dot] se

Profile in Lund University Research Portal

Anja Meissner - New treatments for cardiovascular diseases